Multimodal management of gastroesophageal junction adenocarcinoma: Which type of neoadjuvant treatment?

E Zandirad; Hugo Teixeira-Farinha; Nicolas Demartines; Markus Schäfer; Styliani Mantziari

doi:https://doi.org/10.1093/bjs/znab202.002

doi.org/10.1093/bjs/znab202.002

Multimodal management of gastroesophageal junction adenocarcinoma: Which type of neoadjuvant treatment?

E Zandirad,

Hugo Teixeira-Farinha

2

,

..., Styliani Mantziari

13

British Journal of Surgery9.60

Volume: 108, Issue: Supplement_4

Published: May 1, 2021

Abstract

Objective The current treatment for locally advanced gastroesophageal junction (GEJ) adenocarcinoma consists of neoadjuvant treatment (NAT) followed by surgery. Preoperative chemotherapy (CT) and radio-chemotherapy (RCT) are both valid options, but comparative data for their efficacy remain scarce. This study aimed to assess the efficacy of RCT and CT to achieve a complete pathologic response (CPR) for locally advanced GEJ adenocarcinoma....